BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1596903)

  • 1. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy.
    Ransom JH; Pelle B; Hanna MG
    Cancer Res; 1992 Jun; 52(12):3460-6. PubMed ID: 1596903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of HLA class I and II antigens in colon cancer.
    McDougall CJ; Ngoi SS; Goldman IS; Godwin T; Felix J; DeCosse JJ; Rigas B
    Cancer Res; 1990 Dec; 50(24):8023-7. PubMed ID: 2123744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
    Pfizenmaier K; Bartsch H; Scheurich P; Seliger B; Ucer U; Vehmeyer K; Nagel GA
    Cancer Res; 1985 Aug; 45(8):3503-9. PubMed ID: 3160456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of HLA class I and II expression on a human tumor derived cell line by 5-azacytidine, bacterial lipopolysaccharide, gamma interferon and a phorbol ester.
    Santamaría M; Muñoz E; Molina I; Ortega C; Peña J
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):269-72. PubMed ID: 2474117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
    Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
    Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
    Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
    Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon.
    Kantor J; Tran R; Greiner J; Pestka S; Fisher PB; Shively JE; Schlom J
    Cancer Res; 1989 May; 49(10):2651-5. PubMed ID: 2496918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
    Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines.
    Videira PA; Calais FM; Correia M; Ligeiro D; Crespo HJ; Calais F; Trindade H
    Urology; 2009 Oct; 74(4):944-50. PubMed ID: 19428084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.